Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a ...

Biovac has secured a $108.3 million financing package that will allow the South African pharma company to build the continent ...

In a blow to Bayer, a U.S. federal judge in Manhattan has said he will not block Johnson & Johnson’s survival claims on a key ...

Neurogene is looking to make the leap from a clinical biotech to a commercial biopharma with its lead gene therapy and has ...

Biogen and Minor League Baseball’s Durham Bulls are joining forces to celebrate “America 250” in the Triangle Community.  | ...

Theramex has opted out of the U.K.’s self-regulatory program for pharma ma | Theramex has opted out of the U.K.’s ...

AbbVie is running a new psoriasis campaign based on feedback from real patients about how the condition affects their daily ...

Following a quiet stretch, the legal back-and-forth over migraine meds from Teva and Eli Lilly has resurfaced, with Teva ...

Even as Eli Lilly gets underway with its next major obesity launch in Foundayo, an FDA document related to the oral treatment ...

As biosimilar competition to Johnson & Johnson’s Stelara continues to chew off sales, the much-anticipated launch of the ...

The FDA’s Pharmacy Compounding Advisory Committee will meet this summer to discuss whether certain peptides from compounding ...

Axplora leaders share how CDMO partnerships accelerate complex drug development and speed therapies to patients.